Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management

Ann Hematol. 2024 Mar;103(3):1013-1014. doi: 10.1007/s00277-023-05561-3. Epub 2023 Nov 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • Leukemia, Erythroblastic, Acute* / diagnosis
  • Leukemia, Erythroblastic, Acute* / genetics
  • Leukemia, Erythroblastic, Acute* / therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
  • Mutation
  • Tumor Suppressor Protein p53 / genetics

Substances

  • Fusion Proteins, bcr-abl
  • TP53 protein, human
  • Tumor Suppressor Protein p53